HNN3.0
Register
Register
Register

Project cooperationUpdated on 2 January 2026

GRAD: Your Expert Partner in AI, Digital Twins and Predictive Health

european project manager at Gradiant

Vigo, Spain

About

At Gradiant, we work at the intersection of data science, clinical insight and technological innovation to push healthcare toward a more predictive, preventive and personalised future. Our teams have spent years developing algorithms capable of anticipating clinical events before they manifest, detecting subtle patterns that signal deterioration, and supporting professionals with tools that enhance(not replace) their expertise.

A significant part of our work focuses on predictive modelling for relapse and risk evolution. We design machine‑learning systems that learn from complex, heterogeneous datasets: clinical histories, physiological signals, behavioural indicators and imaging data. These models help identify early warning signs that might otherwise go unnoticed, enabling clinicians to intervene sooner and more effectively. We also have extensive experience in early detection and screening, where our AI‑based solutions analyse large volumes of data to uncover patterns invisible to the human eye. Whether it’s identifying anomalies in medical images, flagging subtle changes in patient trajectories or supporting large‑scale screening programmes, our technologies are built to be both accurate and clinically meaningful.

Medical imaging is another of our core strengths. Over the years, we have developed advanced computer‑vision systems capable of segmentation, classification and anomaly detection across modalities such as MRI, CT, ultrasound and dermoscopy. These tools support diagnostic workflows, reduce workload and improve consistency in clinical assessments. Our work with Digital Human Twins brings all these capabilities together. By creating dynamic, personalised models that simulate an individual’s physiological and behavioural evolution, we enable the exploration of “what‑if” scenarios, personalised treatment planning and continuous monitoring strategies. This approach opens the door to a new generation of health‑management tools that adapt to each patient’s unique profile.

We invite potential partners to explore our website, where you can find detailed information about our ongoing and completed projects in digital health, predictive analytics, imaging and digital twins. Our track record reflects not only technical excellence but also a strong commitment to impactful collaboration.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Similar opportunities

  • Project cooperation

    Biosensing and Digital Prevention Solutions for NCDs, infections and mental health disorders

    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    Joude Cachoux

    Business Development Manager, PharmD, MPH at LEITAT

    Barcelona, Spain

  • Project cooperation

    AI-Driven Digital Health Platform for Predictive, Preventive, and Personalised Care

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    Ioannis Gkouzionis

    CEO at Aisthesis Medical

    London, United Kingdom

  • Project cooperation

    Machine Learning R&D Services

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    SEREF BURAK SELVI

    Technical Leader at Selvi Technology

    Ankara, Türkiye